from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0676c/mmpL5

LFCtreatmentdescriptionclass of inhibitor

-0.920

Amikacinug/mL Amikacintranslation

-1.043

Cap5-10ug/mL Capreomycintranslation

-0.942

Rox10-50 ug/mL Roxithromycintranslation

0.186

SM2-5 ug/mL Streptomycintranslation

-1.576

Tet5-10 ug/mL Tetracyclinetranslation

-1.305

Rif0.2-5ug/mL Rifampicintranscription

-0.865

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.914

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.451

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.356

CPZ10-50 ug/mL Chlorpromazinerespiration

3.216

Clofazimine10-13 ug/mL Clofaziminerespiration

2.302

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.655

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.922

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.122

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.363

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.797

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.931

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.319

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.123

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.890

KCN5-20 ug/mL Potassium cyaniderespiration

0.231

NaN30.2-2 mM Sodium aziderespiration

0.007

Nigericin50 uM Nigericinrespiration

1.584

TRC10-150 ug/mL Triclosanrespiration

1.026

TRZ10-25 ug/mL Thioridazinerespiration

0.225

Valinomycin0.5-10 uM Valinomycinrespiration

0.099

ZnSO42 mM ZnSO4respiration

-0.365

menadione6-10 ug/mL Menadionerespiration

-0.069

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.373

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.149

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.216

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.811

NRP_1Non-replicating persistence stage 1dosRassociated

-0.509

Amp0.2mg/mL AmpicillincellWall

-0.799

Cephalexin20-100 ug/mL CephalexincellWall

-0.743

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.007

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.834

EMB10-20 ug/mL EthambutolcellWall

-0.894

Eta12-40 ug/mL EthionamidecellWall

-0.985

INH0.2-0.4 ug/mL IsoniazidcellWall

0.811

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.194

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.877

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.473

BZA0.12 mg/mL BenzamidearomaticAmides

0.360

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.437

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.466

H2O24 mM hydrogen peroxideDNAdamaging

-0.705

Levo10 ug/mL LevofloxacinDNAdamaging

-0.279

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.742

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.820

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.558

UVUV-irradiationDNAdamaging

0.018

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.417

Antimycin12.5-50 ug/mL Antimycin A?

-0.513

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.145

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.025

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.978

PA8240.2-2 ug/mL PA-824?

1.504

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.030

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.989

Verapamil50 uM Verapamil?

-0.486

mercaptoethanol2 mM 2-Mercaptoethanol?

0.218

methoxatin10-20 ug/mL Methoxatin?